AMSBIO announces RapidSeq – new convenient and cost-effective library sample preparation kits for Next Generation Sequencing (NGS) research and diagnostic work.
The RapidSeq Small RNA Sample Prep Kit is optimised for preparation of NGS libraries for subsequent cluster generation, using purified mRNA or total RNA which contains small RNA fragments as input. The protocol includes steps for adapters ligation, reverse transcription, PCR amplification, and size selection by gel purification to generate a library product compatible with a range of commercial NGS platforms.
The RapidSeq Directional mRNA Sample Prep kit provides strand-specific cDNA synthesis with reduced costs and increased sensitivity. Strand-specific RNA-seq improves on standard RNA-seq in three ways: accurately identifying antisense transcripts, determining the transcribed strand of non-coding RNAs (e.g. lincRNAs), and demarcating the boundaries of closely situated or overlapping genes.
In addition using RapidSeq kits your workflow will be simplified as most components are supplied as ready-to-use master mixtures reducing your setup time and liquid handling steps. Offering market-leading performance and a wide dynamic range – RapidSeq provides a turnkey solution for applications including mRNA detection and quantification, mRNA discovery, mRNA expression profiling as well as mRNA related functional assessment and validation.
About AMS Biotechnology
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and development in the medical, nutrition, cosmetics and energy industries. The AMSBIO range includes specialist antibodies, peptides and recombinant proteins. In addition the company is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as experts in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance screening outcomes and eventual prognosis. With a range of molecular detection reagents, and a significant Biorepository the company can also provide tissue DNA, RNA, protein and microarray products. Key research areas for these products include: Oncology, Regenerative Medicine, Environmental Analysis, Cytotoxicity Screening, Glycomics and Stem Cell Biology.